E2F1 and breast cancer: They supposed that METTL3 promoted expression of metastasis associated lung adenocarcinoma transcript 1 (MALAT1, which recruited E2F transcription factor 1 (E2F1) to activate transcription of anterior gradient 2 (AGR2), thus desensitize BC cells to DOX [66].